Online inquiry

IVTScrip™ mRNA-Human AFTPH, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK8987MR)

This product GTTS-WK8987MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the AFTPH protein. This product can be used in Regulatory T (Treg) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001002243.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 54812
UniProt ID Q6ULP2
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AFTPH, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK8987MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK8891MR IVTScrip™ mRNA-Human ADAM17, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADAM17
GTTS-WK20932MR IVTScrip™ mRNA-Human ANKRD6, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ANKRD6
GTTS-WK26492MR IVTScrip™ mRNA-Human ARHGAP28, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ARHGAP28
GTTS-WK9531MR IVTScrip™ mRNA-Human ADGB, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ADGB
GTTS-WK17639MR IVTScrip™ mRNA-Human ANKS4B, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ANKS4B
GTTS-WK25501MR IVTScrip™ mRNA-Human APCDD1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA APCDD1
GTTS-WK11227MR IVTScrip™ mRNA-Human ACKR3, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ACKR3
GTTS-WK28403MR IVTScrip™ mRNA-Human ASCC2, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ASCC2
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →